Home > Financial Ratios > BETA DRUGS

BETA DRUGS
Fixed Capital/Sales

    Back to All Ratios
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.350.350.400.390.51

What is the latest Fixed Capital/Sales ratio of BETA DRUGS ?

The latest Fixed Capital/Sales ratio of BETA DRUGS is 0.35 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.35
Mar20240.35
Mar20230.40
Mar20220.39
Mar20210.51

How is Fixed Capital/Sales of BETA DRUGS Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.35
0.00
Mar2024 0.35
-12.50
Mar2023 0.4
2.56
Mar2022 0.39
-23.53
Mar2021 0.51 -

Other Financial Ratios of BETA DRUGS


Compare Fixed Capital/Sales ratio of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,292.0 Cr -1.6% -17.5% 13.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -2.5% -4.7% 15.5% Stock Analytics
DIVIS LABORATORIES ₹244,223.0 Cr -4% 8.1% 55.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹183,453.0 Cr -2.3% 0.2% 36.6% Stock Analytics
CIPLA ₹109,849.0 Cr -1.7% -6.1% -12% Stock Analytics
DR REDDYS LABORATORIES ₹95,591.8 Cr -0.2% -4.4% -10.2% Stock Analytics


BETA DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

-1.6%

-17.5%

13.1%

SENSEX

-1.6%

-4.7%

-8.3%


You may also like the below Video Courses